What is PneumoWave?
Founded in 2018, PneumoWave is dedicated to revolutionizing respiratory care by shifting the focus from treatment to early intervention. The company's core mission is to prevent deaths and reduce hospital admissions through the capture and analysis of real-time physiological signals. By providing advanced insights into respiratory health, PneumoWave aims to enable a paradigm shift in how respiratory conditions are managed, moving towards a more preventative and intervention-focused model.
How much funding has PneumoWave raised?
PneumoWave has raised a total of $9.1M across 1 funding round:
Series A
$9.1M
Series A (2023): $9.1M with participation from Scottish Enterprise, Alba Equity, and Scottish National Investment Bank
Key Investors in PneumoWave
Scottish Enterprise
Founded in 1991, Scottish Enterprise is headquartered in Glasgow, United Kingdom. They are a national economic development agency and a non-departmental public body of the Scottish Government.
Alba Equity
Alba Equity is an investment syndicate based in Aberdeen that focuses on investing in businesses with high growth potential. They provide capital and leverage the experience, time, and connections of their members to assist in business development.
Scottish National Investment Bank
The Scottish National Investment Bank is a development investment bank established to provide long-term, patient capital investments for businesses, projects, and communities across Scotland. Its mission is to support the development of a fairer and more sustainable economy.
What's next for PneumoWave?
The recent major strategic investment positions PneumoWave for accelerated development and market expansion. This capital infusion is expected to fuel advancements in their technology, enhance their data analytics capabilities, and broaden their reach within the healthcare sector. The company's focus on preventing severe respiratory issues aligns with a growing global demand for proactive health management solutions, suggesting a strong potential for future growth and impact.
See full PneumoWave company page
